PharmaCyte Biotech, Inc. — Investor Relations & Filings

PharmaCyte Biotech, Inc. is a clinical-stage biotechnology company focused on developing and commercializing cellular therapies for cancer and diabetes. The company's core platform is its proprietary Cell-in-a-Box® technology, a cellulose-based live-cell encapsulation system. This technology involves encapsulating genetically engineered living cells that can produce and deliver therapeutic agents in a targeted manner when implanted in the body. The primary application under development is for the treatment of locally advanced, inoperable pancreatic cancer and other solid tumors, where the encapsulated cells are designed to convert an inactive chemotherapy drug into its active form at the tumor site.